drugset / Trial / NCT00849576

Effect of Treatment With Insulin VIAjectTM Compared to Regular Human Insulin and Insulin Lispro on Mealtime Blood Vessel Stress in Patients With Type 2 Diabetes Mellitus.

NCT00849576

Phase 3 Completed 15 enrolled Biodel
Non-randomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to compare the effects of insulin VIAject with Regular Human Insulin and Insulin Lispro on measures of mealtime blood vessel stress and blood flow.

Timeline

Start
2008-04
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Insulin Protein / enzyme biologic 0.1 iu/kg
Comparator Insulin Lispro Protein / enzyme biologic 90 %
Subject Insulin VIAject™ Unknown 75 %
Subject Insulin VIAject™ Unknown 90 %